Global Anti-Inflammatory Therapeutics Market (Treatment of Disease, Class and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020
  • Published : June , 2015
  • |
  • Published By : Allied Market Research



Report Overview

Anti-Inflammatory Therapeutics are used to reduce inflammation and are used in the treatment of Arthritis, Respiratory diseases, multiple sclerosis and others. The Anti-inflammatory therapeutics reduce and prevent the secretion of prostaglandins the cause of inflammation. The incidences of conditions in which inflammation causes serious adverse effects are rising. Inflammation contributes significantly to the development of artherosclerosis plaques. The incidence of artherosclerosis is on the rise and is the major driver for this market. Also, there are newer and novel treatments being developed with significant investment in research and development, which would also add to the growth of this market. The challenges that need to be addressed are the large number of side effects associated with the anti-inflammatory drugs currently in use. The regulations laid down for approval are stringent, which could impede the growth of this market. Opportunities for this market would be tremendous, as the launch of new drugs with fewer side effects and higher specificities would be in high demand.

Anti-Inflammatory Therapeutics Market by use in Treatment of Disease

Anti-Inflammatory Therapeutics is used for the treatment of Arthritis, Respiratory diseases, Multiple Sclerosis Spondyloarthropathies, Psoriasis, Gout, and Inflammatory bowel disease. According to the Multiple Sclerosis International Federation, the number of individuals suffering from MS has increased from 2.1 million in 2008 to 2.3 million in 2013. According to the CDC, an estimated 1.5 million people had arthritis in 2005. All these disease require anti-inflammatory therapeutics for their treatment and would spur demand for newer drugs.

Anti-Inflammatory Therapeutics Market by Class

Anti- inflammatory therapeutics belongs to two classes, Immune selective anti-inflammatory derivatives and Non-Steroidal anti-inflammatory drugs. (NSAID).The immune selective anti-inflammatory derivatives act by blocking the inflammatory cells that increase inflammation and are relatively newer class of drugs. This class of drugs are promising derivatives for treatment of anti-inflammatory conditions.

Anti-Inflammatory Therapeutics Market by Geography

Anti- inflammatory therapeutics is segmented into North America, Europe, Asia Pacific and RoW. North America has the largest market as the incidences of disease are on the rise and companies have come up with new drugs. Asia Pacific would be an emerging market as health awareness is growing in this region.

Competitive Analysis

The companies involved in research and manufacture of ant-inflammatory therapeutics are Amgen Inc., Abbott Laboratories, Astra Zenca, Novartis, MorphoSys AG, Sanofi Aventis and others. In Feb 2014, MorphoSys AG announced that it received a payment from Novartis for clinical trial application and initiation of Phase 1 clinical trials for its drug, HuCAL-, which is being developed as a therapeutic for inflammatory diseases.

High Level Analysis

Porters five force model helps in analysis of the bargaining power of the buyers and suppliers. The bargaining power of the buyer in this market is high, as there are many anti-inflammatory drugs available. The threat of new entrants in this market is moderate due to the high investments required for development of anti-inflammatory drugs. Need for improved anti-inflammatory drugs with fewer side effects are driving the market. SWOT analysis would help in understanding competitive strategies adopted by companies. The key drivers and opportunities would help in assessing the growth of this market.

Key Benefits

  • The market estimations of therapeutic, class and geographic segments are based on the current market scenario and expected market trends
  • Key development strategies adopted by leading market players in the Anti-inflammatory market are analyzed so that companies involved in development of anti-inflammatory drugs can understand the competitive decisions taken by their competitors
  • Porters five force model, and value chain analysis are analyzed and presented in detail so that decisions can be taken after understanding the market scenario
  • Market segmentation has been carried out for various products, their application and their demand in different regions with a detailed analysis of factors responsible for their future growth
  • Current market dynamics is elaborated upon with their impact analysis.

Anti-Inflammatory Therapeutics Market by use in Treatment of Disease

  • Arthritis
  • Respiratory diseases
  • Multiple Sclerosis
  • Spondyloarthropathies
  • Psoriasis
  • Gout
  • Inflammatory bowel disease

Anti-Inflammatory Therapeutics Market by Class

  • Immune selective anti-inflammatory derivatives
  • Non-Steroidal anti-inflammatory drugs

Anti-Inflammatory Therapeutics Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • RoW



Similar Market Studies

PUBLISHED REPORTS


UPCOMING REPORTS


Reports and Intelligence


We Accept

  • Stay Connected

Copyright ©2017 Reportsandintelligence All Rights Reserved